Antiretroviral therapy for previously untreated HIV-1-infected adults: 2NN, or just one?

被引：5

作者：

Carr, A ^{[1
]}

机构：

[1] St Vincents Hosp, Sydney, NSW 2010, Australia

来源：

LANCET | 2004年 / 363卷 / 9417期

关键词：

D O I：

10.1016/S0140-6736(04)16028-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1248 / 1250

页数：3

共 16 条

[1]

BARTLETT JA, 2002, 14 INT AIDS C BARC J

[2]

Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8

[3]

DELFRAISSY JF, 2002, 6 INT C DRUG THER HI

[4]

*DHHS HJ KAIS FAM, GUID US ANT AG HIV 1

[5] Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study [J].

Fellay, J ;

Boubaker, K ;

Ledergerber, B ;

Bernasconi, E ;

Furrer, H ;

Battegay, M ;

Hirschel, B ;

Vernazza, P ;

Francioli, P ;

Greub, G ;

Flepp, M ;

Telenti, A .

LANCET, 2001, 358 (9290) :1322-1327

[6]

GALLANT JE, 2003, 43 INT C ANT AG CHEM

[7]

HALL D, 2004, 11 C RETR OPP INF SA, P694

[8]

MONTANER JSG, 2001, 41 INT C ANT AG CHEM

[9]

*NAT I HLTH NAT I, IMP INT RES PHAS 3 R

[10]

National Cholesterol Education Program (U.S.), RISK ASS TOOL EST YO

← 1 2 →